Hyaluronan in cervical epithelia protects against infection-mediated preterm birth

Journal of Clinical Investigation

Volumn 124, Issue 12, 2014, Pages 5481-5489

  Akgul, Yucel ^a   Word, R Ann ^a   Ensign, Laura M ^b   Yamaguchi, Yu ^c   Lydon, John ^d   Hanes, Justin ^b   Mahendroo, Mala ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BURNHAM INSTITUTE   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CERVICAL COMPLIANCE; COMPLIANCE (PHYSICAL); CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT PARAMETERS; INFECTION PREVENTION; MALE; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PREMATURE LABOR; PROTEIN DEPLETION; PROTEIN FUNCTION; THIRD TRIMESTER PREGNANCY; UTERINE CERVIX; UTERINE CERVIX EPITHELIUM; UTERINE CERVIX MUCOSA; UTERUS FUNCTION; VAGINA; VAGINITIS; ANIMAL; EPITHELIUM; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MICROBIOLOGY; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE BIRTH;

ANIMALS; CERVIX UTERI; EPITHELIUM; FEMALE; HYALURONIC ACID; MICE; MICE, KNOCKOUT; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84915750047     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI78765     Document Type: Article

References (33)

1. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Mathews TJ. Births: final data for 2011. Natl Vital Stat Rep. 2013;62(1):1-69.
2. Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol. 1988;31(3):553-584.
3. Romero R, Chaiworapongsa T, Espinoza J. Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response syndrome. J Nutr. 2003;133(5 suppl 2):1668S-1673S.
4. Akgul Y, Mahendroo M. Cervical changes accompanying birth. In: Croy BA, Yamada AT, DeMayo FJ, Adamson SL, eds. The Guide to Investigation of Mouse Pregnancy. Boston, Massachusetts, USA: Academic Press; 2014:391-401.
5. Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J. Williams Obstetrics 24/E. 24th ed. New York, New York, USA: McGraw Hill Professional; 2014.
6. Ruscheinsky M, De la Motte C, Mahendroo M. Hyaluronan and its binding proteins during cervical ripening and parturition: dynamic changes in size, distribution and temporal sequence. Matrix Biol. 2008;27(5):487-497.
7. Osmers R, Rath W, Pflanz MA, Kuhn W, Stuhlsatz HW, Szeverenyi M. Glycosaminoglycans in cervical connective tissue during pregnancy and parturition. Obstet Gynecol. 1993;81(1):88-92.
8. Tateyama N, Asakura H, Takeshita T. Correlation between an absence of cervical gland area on transvaginal sonography and cervical mucus hyaluronic acid levels in women with threatened preterm delivery. J Perinat Med. 2013;41(2):151-157.
9. Akgul Y, Holt R, Mummert M, Word A, Mahendroo M. Dynamic changes in cervical glycosaminoglycan composition during normal pregnancy and preterm birth. Endocrinology. 2012;153(7):3493-3503.
10. Straach KJ, Shelton JM, Richardson JA, Hascall VC, Mahendroo MS. Regulation of hyaluronan expression during cervical ripening. Glycobiology. 2005;15(1):55-65.
11. Akins ML, Luby-Phelps K, Bank RA, Mahendroo M. Cervical softening during pregnancy: regulated changes in collagen cross-linking and composition of matricellular proteins in the mouse. Biol Reprod. 2011;84(5):1053-1062.
12. Dicker KT, Gurski LA, Pradhan-Bhatt S, Witt RL, Farach-Carson MC, Jia X. Hyaluronan: A simple polysaccharide with diverse biological functions. Acta Biomaterialia. 2014;10(4):1558-1570.
13. Camenisch TD, et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest. 2000;106(3):349-360.
14. Kobayashi N, et al. Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization. Cancer Res. 2010;70(18):7073-7083.
15. Bai K-J, et al. The role of hyaluronan synthase 3 in ventilator-induced lung injury. Am J Respir Crit Care Med. 2005;172(1):92-98.
16. Soyal SM, et al. Cre-mediated recombination in cell lineages that express the progesterone receptor. genesis. 2005;41(2):58-66.
17. Timmons B, Akins M, Mahendroo M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol Metab. 2010;21(6):353-361.
18. Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol. 2003;4(9):721-732.
19. Blaskewicz CD, Pudney J, Anderson DJ. Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia. Biol Reprod. 2011;85(1):97-104.
20. Spicer AP, Tien JY. Hyaluronan and morphogenesis. Birth Defects Res C Embryo Today. 2004;72(1):89-108.
21. Lai SK, et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci U S A. 2007;104(5):1482-1487.
22. Ensign LM, et al. Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci Transl Med. 2012;4(138):138ra79.
23. Muglia LJ, Katz M. The enigma of spontaneous preterm birth. N Engl J Med. 2010;362(6):529-535.
24. Iams JD, Romero R, Culhane JF, Goldenberg RL. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet. 2008;371(9607):164-175.
25. Hill DR, et al. Human milk hyaluronan enhances innate defense of the intestinal epithelium. J Biol Chem. 2013;288(40):29090-29104.
26. Critchfield AS, et al. Cervical mucus properties stratify risk for preterm birth. PLoS One. 2013;8(8):e69528.
27. Kirschner N, et al. CD44 regulates tight-junction assembly and barrier function. J Invest Dermatol. 2010;131(4):932-943.
28. Bourguignon LY. Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions. Am J Pathol. 2014;184(7):1912-1919.
29. Oestergaard MZ, et al. Neonatal mortality levels for 193 countries in 2009 with trends since 1990: a systematic analysis of progress, projections, and priorities. PLoS Med. 2011;8(8):e1001080.
30. Matsumoto K, et al. Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb. Development. 2009;136(16):2825-2835.
31. Akgul Y, Mahendroo M. Assessment of changes in the peripartum cervix. In: Croy BA, Yamada AT, DeMayo FJ, Adamson SL, eds. The Guide to Investigation of Mouse Pregnancy. Boston, Massachusetts, USA: Academic Press; 2014:723-731.
32. Calabro A, Benavides M, Tammi M, Hascall VC, Midura RJ. Microanalysis of enzyme digests of hyaluronan and chondroitin/dermatan sulfate by fluorophore-assisted carbohydrate electrophoresis (FACE). Glycobiology. 2000;10(3):273-281.
33. Carson FL, Hladik C. Histotechnology: A Self-Instructional Text. Chicago, Illinois, USA: ASCP Press; 2009.